10/03/2014

SEFAC AND ESTEVE WILL COLLABORATE IN THE DEVELOPMENT OF NEW TECHNOLOGIES IN COMMUNITY PHARMACY

The two entities have signed a framework agreement whereby several courses of action are planned. The first will be the performance of a study on the use of electronic prescriptions and health insurance cards in Spanish pharmacies.

SEFAC and ESTEVE will also work on the development and promotion of new information technologies and new mobile applications aimed at improving therapeutic adherence and facilitate care provided by community pharmacists.

As part of this collaboration, ESTEVE will sponsor a roundtable titled From Science to Technology at the VI National Congress of Community Pharmacists, to be held by SEFAC on May 23 in Malaga, Spain.

The Spanish Society of Community Pharmacy (SEFAC) and ESTEVE have signed a framework agreement whereby both entities will collaborate to train on, investigate and foster new technologies used in community pharmacy. Jesús C. Gómez, chairman of SEFAC, and Eugeni Sedano, ESTEVE's Director of Institutional Relations, signed the agreement which, among other activities, envisages the performance of a study on the implementation and operation of electronic prescriptions and health insurance cards in Spain.

This study is already underway, coordinated by SEFAC's Commission on electronic prescriptions and health insurance cards, and has two objectives: one, to perform a thorough analysis of the characteristics of electronic prescriptions in the autonomous communities where electronic prescriptions are already implemented in different phases; and two, to conduct a national survey, hosted at www.sefac.org, to ascertain the opinion of community pharmacists on this tool. This work analyzes aspects such as the general usefulness of electronic prescriptions; whether these have allowed improving the quality of healthcare and the rational use of drugs; the extent to which patients benefit from them and bureaucracy is reduced; whether they are helping care provided by community pharmacists; pros and cons; and the changes that could or should be implemented to improve operation, among other subjects.

In addition, the agreement between SEFAC and ESTEVE also envisages the collaboration of both entities to develop, promote and disseminate new technologies and applications likely to help improve the quality of healthcare among community pharmacists and the communication of these with the rest of healthcare disciplines and with patients.

In this context, ESTEVE will sponsor a roundtable titled From Science to Technology at the VI National Congress of Community Pharmacists, to be held by SEFAC on May 23 in Malaga under the motto "Making a Difference". This table will address the different technological tools used to support healthcare as provided by pharmacists, ranging from pharmacogenomics- and therapeutic adherence-related computer programs to mobile terminal applications, including ESTEVE's expertSalud application designed to improve self-care.


You can follow ESTEVE on Twitter at this link: twitter.com/esteve_news.

Related Information

Last news

  • ESTEVE ANNOUNCES A RESTRUCTURING OF ITS PHARMACEUTICAL ACTIVITY

    Esteve Pharmaceuticals submits a reduction in force (RIF) which will affect 103 jobs in Spain

    read more
  • NURSES OFFER CARE AND PREVENTION OF DRY EYE, A CONDITION THAT AFFECTS 60% OF PEOPLE OLDER THAN 45 YEARS

    Dry eye care and prevention is a pending issue in the Spanish society and a source of great concern for specific patients, such as those admitted to Intensive Care Units.

    The longer time...

    read more
  • ONE THIRD OF DIABETIC PATIENTS ARE OLDER THAN 75 YEARS AND THEIR HYPOGLYCEMIA GOES UNDETECTED IN 1 OUT OF 5 CASES

    According to experts attending Diabeclass, a meeting organized by ESTEVE
    at its corporate headquarters titled "Managing elderly patients with
    type 2 diabetes".

    The priority ...

    read more

Follow us at

This Website uses its own and third-party cookies to improve our services and analyse the user's browsing habits. If you continue browsing, we will consider you to have accepted their use. You can find more information by visiting our Cookies policy.